Comparison of a standard CO₂ pressure pneumoperitoneum insufflator versus AirSeal: study protocol of a randomized controlled trial

Ruzica Rosalia Luketina, Michael Knauer, Gernot Köhler, Oliver Owen Koch, Klaus Strasser, Margot Egger, Klaus Emmanuel, Ruzica Rosalia Luketina, Michael Knauer, Gernot Köhler, Oliver Owen Koch, Klaus Strasser, Margot Egger, Klaus Emmanuel

Abstract

Background: AirSeal is a novel class of valve-free insufflation system that enables a stable pneumoperitoneum with continuous smoke evacuation and carbon dioxide (CO₂) recirculation during laparoscopic surgery. Comparison data to standard CO₂ pressure pneumoperitoneum insufflators is scarce. The aim of this study is to evaluate the potential advantages of AirSeal compared to a standard CO₂ insufflator.

Methods/design: This is a single center randomized controlled trial comparing elective laparoscopic cholecystectomy, colorectal surgery and hernia repair with AirSeal (group A) versus a standard CO₂ pressure insufflator (group S). Patients are randomized using a web-based central randomization and registration system. Primary outcome measures will be operative time and level of postoperative shoulder pain by using the visual analog score (VAS). Secondary outcomes include the evaluation of immunological values through blood tests, anesthesiological parameters, surgical side effects and length of hospital stay. Taking into account an expected dropout rate of 5%, the total number of patients is 182 (n = 91 per group). All tests will be two-sided with a confidence level of 95% (P <0.05).

Discussion: The duration of an operation is an important factor in reducing the patient's exposure to CO₂ pneumoperitoneum and its adverse consequences. This trial will help to evaluate if the announced advantages of AirSeal, such as clear sight of the operative site and an exceptionally stable working environment, will facilitate the course of selected procedures and influence operation time and patients clinical outcome.

Trial registration: ClinicalTrials.gov NCT01740011, registered 23 November 2012.

References

    1. Junghans T, Bohm B, Grundel K, Schwenk W. Effects of pneumoperitoneum with carbon dioxide, argon, or helium on hemodynamic and respiratory function. Arch Surg. 1997;132:272–278. doi: 10.1001/archsurg.1997.01430270058012.
    1. Neuhaus SJ, Gupta A, Watson DI. Helium and other alternative insufflation gases for laparoscopy. Surg Endosc. 2001;15:553–560. doi: 10.1007/s004640080060.
    1. Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg. 2005;241:219–226. doi: 10.1097/01.sla.0000151791.93571.70.
    1. Nyerges A. Pain mechanisms in laparoscopic surgery. Semin Laparosc Surg. 1994;1:215–218.
    1. Callery MP, Soper NJ. Physiology of the pneumoperitoneum. Baillieres Clin Gastroenterol. 1993;7:757–777. doi: 10.1016/0950-3528(93)90014-J.
    1. Carey PD, Wakefield CH, Thayeb A, Monson JR, Darzi A, Guillou PJ. Effects of minimally invasive surgery on hypochlorous acid production by neutrophils. Br J Surg. 1994;81:557–560. doi: 10.1002/bjs.1800810425.
    1. Bohm B, Milsom JW, Fazio VW. Postoperative intestinal motility following conventional and laparoscopic intestinal surgery. Arch Surg. 1995;130:415–419. doi: 10.1001/archsurg.1995.01430040077017.
    1. Chekan EG, Nataraj C, Clary EM, Hayward TZ, Brody FJ, Stamat JC, Fina MC, Eubanks WS, Westcott CJ. Intraperitoneal immunity and pneumoperitoneum. Surg Endosc. 1999;13:1135–1138. doi: 10.1007/s004649901189.
    1. Berguer R, Dalton M, Ferrick D. Adrenocortical response and regional T-lymphocyte activation patterns following minimally invasive surgery in a rat model. Surg Endosc. 1998;12:236–240. doi: 10.1007/s004649900642.
    1. Bessler M, Whelan RL, Halverson A, Treat MR, Nowygrod R. Is immune function better preserved after laparoscopic versus open colon resection? Surg Endosc. 1994;8:881–883. doi: 10.1007/BF00843460.
    1. Griffith JP, Everitt NJ, Lancaster F, Boylston A, Richards SJ, Scott CS, Benson EA, Sue- Ling HM, McMahon MJ. Influence of laparoscopic and conventional cholecystectomy upon cell-mediated immunity. Br J Surg. 1995;82:677–680. doi: 10.1002/bjs.1800820539.
    1. Klava A, Windsor A, Boylston AW, Reynolds JV, Ramsden CW, Guillou PJ. Monocyte activation after open and laparoscopic surgery. Br J Surg. 1997;84:1152–1156. doi: 10.1002/bjs.1800840832.
    1. Kloosterman T, von Blomberg BM, Borgstein P, Cuesta MA, Scheper RJ, Meijer S. Unimpaired immune functions after laparoscopic cholecystectomy. Surgery. 1994;115:424–428.
    1. Mealy K, Gallagher H, Barry M, Lennon F, Traynor O, Hyland J. Physiological and metabolic responses to open and laparoscopic cholecystectomy. Br J Surg. 1992;79:1061–1064. doi: 10.1002/bjs.1800791024.
    1. Tsimoyiannis EC, Glantzounis G, Lekke ET, Siakas P, Jabaria M, Tszourou H. Intraperitoneal normal saline and bupivacaine infusion for reduction of post-operative pain after laparoscopic cholecystectomy. Surg Laparos Endos. 1998;8:416–420. doi: 10.1097/00019509-199812000-00003.
    1. Wallace DH, Serpell MG, Bakter JN, O’ Dwyer PJ. Randomized trial of different insufflation pressure for laparoscopic cholecystectomy. Br J Surg. 1997;84:455–458. doi: 10.1002/bjs.1800840408.
    1. Barczynski M, Herman RM. A prospective randomized trial on comparison of low-pressure (LP) and standard pressure (SP) pneumoperitoneum for laparoscopic cholecystectomy. Surg Endosc. 2003;17:533–538. doi: 10.1007/s00464-002-9121-2.
    1. Pier A, Benedic M, Mann B, Buck V. Post laparoscopic pain syndrome. Results of a prospective, randomized study. Chirurg. 1994;65:200–208.
    1. Herati AS, Atalla MA, Rais-Bahrami S, Andonian S, Vira MA, Kavoussi LR. A new valve-less trocar for urologic laparoscopy: initial evaluation. J Endourol. 2009;23:1535–1539. doi: 10.1089/end.2009.0376.
    1. Herati AS, Andonian S, Rais-Bahrami S, Atalla MA, Srinivasan AK, Richstone L, Kavoussi LR. Use of the valveless trocar system reduces carbon dioxide absorption during laparoscopy when compared with standard trocars. Urology. 2011;77:1126–1132. doi: 10.1016/j.urology.2010.06.052.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren